Key Takeaways AUNA's Peru revenues rose 11% YoY, driven by high-complexity services and new medical investments.AUNA's adjusted EBITDA in Peru grew 14%, with margins improving to 22.4% in Q4 2025.AUNA's Oncosalud revenues increased 10%, aided by membership growth and lower oncology MLR at 48.5%.Auna S.A.’s (AUNA) Peru business underscores the strength and predictability of its integrated healthcare model operating at scale. The segment remained a bright spot in the fourth quarter of 2025, with revenues incr ...